Remove Capital Remove Class Remove Funding Remove San Diego
article thumbnail

Hone Gets $16M For Corporate Training

socalTECH

San Diego-based Hone, a provider of a corporate learning platform, has raised $16M in a Series A funding round. The funding was F-Prime Capital and also included Cowboy Ventures, NextGen Venture Partners, Slack Fund, Gaingels, Swift Ventures, and SemperVirens. Hone is led by CEO Tom Griffiths.

Training 100
article thumbnail

TuSimple Prices IPO, Starts Trading Today

socalTECH

San Diego-based TuSimple priced its IPO last night, saying that it will sell 33,783,783 shares of its Class A common stock at the price of $40.00 Morgan, along withBofA Securities, Cowen, Credit Suisse, Nomura and RBC Capital Markets, Baird, Needham & Company, Oppenheimer & Co., Piper Sandler and Valuable Capital.

Pricing 113
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Upfront Ventures Raised New $280 Million Fund

Both Sides of the Table

We’ve been dying to tell you all for a while that we had raised a new venture capital fund and of course given SEC filing requirements the story was somewhat already scooped by the always-in-the-know Dan Primack a few weeks ago. Wait, didn’t you just raise a fund? We raised $280 million.

article thumbnail

VelosBio Finds $137M For Oncology Efforts

socalTECH

San Diego-based biopharmaceuticals developer VelosBio says it has raised $137M in a Series B funding roudn, to go towards its oncology efforts. Venrock Healthcare Capital Partners, Viking Global Investors, Wellington Management Company, as well as the company's existing investors. Rowe Price Associates, Inc.,

San Diego 113
article thumbnail

Cardiff Oncology Raises $13.5M

socalTECH

San Diego-based Cardiff Oncology said this morning that it has raised $13.5M in an equity funding round. The company, which is working on drugs to treat cancer, said the funding was led by Acorn Bioventures and CAM Capital. The company is led by CEO Dr. Mark Erlander. READ MORE>>.

San Diego 113
article thumbnail

VelosBio Emerges with $58M in Funding to Steer Cancer Drugs to Clinic

Xconomy

VelosBio joined Johnson & Johnson’s JLABS @ San Diego incubator in January. The company is developing antibody drug conjugates, a class of cancer drug that links antibodies to potent cancer-fighting toxins. The new VelosBio cash, a Series A round of financing, was led by Arix Bioscience (LSE: ARIX ) and Sofinnova Ventures.

article thumbnail

The top 10 cities for $100M VC rounds in 2018 so far

TechCrunch LA

Jason Rowley is a venture capital and technology reporter for Crunchbase News. We’ve called these nine and 10-figure deals, which shine brightly in the media and are hefty enough to bend the curve of VC fund sizes upwards, “ supergiants ” after their stellar counterparts. 2018 is already a record year for venture funding worldwide.